Traws Pharma launches at-the-market offering of up to $5.58 million in shares
TRAW•At-the-market equity program
Traws Pharma set up an at-the-market equity program with Citizens JMP Securities to sell common stock.
- Program size capped at USD 50 million under the distribution agreement, subject to limits.
- Current “baby shelf” capacity limits sales under the prospectus supplement to up to USD 5.58 million.
- Shares will be sold from time to time through the agent under the company’s effective Form S-3 shelf registration.
